Speakers

Jason Acker

Professor

University of Alberta, Canada

Taby Ahsan

Director of Development

RoosterBio Inc., USA

Julie Allickson

Director, Regenerative Medicine Clinical Center

Wake Forest Institute for Regenerative Medicine, USA

Eric Alonzo

Scientist, Cellular Analytics

Bluebird Bio

Chris Baldwin

Supply Chain Director

GSK, USA

Sarindr Bhumiratana

CSO, Co-Founder

EpiBone, USA

Wen Bo Wang

Senior Vice President, Technical Operations

Fate Therapeutics, USA

Jennifer Briggs Braswell, PhD

Chief Administrative Officer

ARMI, BioFab, USA

Bruce A Bunnell

Professor

Director of the Tulane Center for Stem Cell Research & Regenerative Medicine, USA

Scott Burger

Principal

Advanced Cell & Gene Therapy, USA

Joseph Carosi

Associate Director

Novartis, USA

Veeren Chauhan

Research Fellow

University of Nottingham, USA

Francesco Cicirello

Chairman of the PIC/S Working Group on the revision of Annex 2

and Deputy Chairman of the PIC/S Sub-Committee on the Harmonisation of GMDP / Pharmaceutical Inspection Co-operation Scheme, Australia

Jakub Cierny

Senior Quality Compliance Manager

Sotio AS, Czech Republic

David Dobnik

Scientific Associate

National Institute of Biology, Slovenia

Steve Elliman

Chief Scientific Officer

Orbsen Therapeutics, USA

Miguel Esteves

Associate Professor, Horae Gene Therapy Center

University of Massachusetts Medical School , USA

Miguel Forte

CEO

Zelluna Immunotherapy, Norway

Eileen Galvin Karr

Apheresis Site Manager

Key Biologics LLC, USA

Guanping Gao

Professor, Microbiology & Physiological Systems, Penelope Booth Rockwell Professor in Biomedical Research, Co-Director, Li Weibo Institute for Rare Diseases Research, Director, Horae Gene Therapy Center and Vector Core, Scientific Director

UMMS-China Program Office, USA

Chris Gemmiti, Ph.D.

Head of Operations

Sentien Biotechnologies Inc.

Dan Gincel

VP University Partnerships, TEDCO Executive Director, MD Stem Cell Research Fund

Maryland Stem Cell Research Fund, USA

Laurie Glimcher, MD

President and CEO

Dana-Farber Cancer Institute

Patrick Hanley

Immunotherapy GMP & Research Assistant Professor & Director

Children's National Health System, USA

John Heffernan

V.P. Commercial Manufacturing

Astellas

Derek Hei

Senior VP, Manufacturing, Quality & Regulatory

BlueRock Therapeutics, USA

Timothy Herpin

Chief Business Officer

Caribou Biosciences

John Hewes

Senior Specialist

Invention Development, DHHS/NIH/NCI Technology Transfer Center, USA

Geoffrey Hodge

Chief Technical Officer

Unum Therapeutics

Meridith Hyres

Senior Specialist, Clinical Supply Management

Biogen, USA

Jian Irish

Global Head of Manufacturing

Kite Pharma, USA

Stuart Jacobsen

ARMI Tissue Foundry Project Manager

DEKA, USA

Amritha Jaishankar

Associate Director

MD Stem Cell Research Fund, USA

Christoph Kahl

Associate Director, Viral Vector Process and Analytics

Atara Biotherapeutics, USA

Ohad Karnieli, Ph.D., MBA

CEO

Atvio Biotech

Eric Kelsic

Co-Founder & CEO

Dyno Therapeutics, USA

David Kim

Director, Supply Chain

Kite, A Gilead Company, USA

Michael Klichinsky

Co-Founder

Carisma Therapeutics

Marcos Langtry

Outsourced Manufacturing and Development Director

TiGenix, Belgium

Michael Leek

Chief Executive

TC BioPharm

Graham Lilley

Process Development Engineer

Caribou Biosciences, Inc., USA

Janet Lynch Lambert

Chief Executive Officer

Alliance for Regenerative Medicine, USA

Jørgen Magnus

Head of Bio-Process Technology

Bayer, AG, Germany

Ginette Michaud

Director, Office of Biological Products Operations

FDA, USA

Amanda Micklus

Principal Analyst

Datamonitor Healthcare

Jeffrey Miller

Professor of Medicine, Deputy Director, Masonic Cancer Center, Division of Hematology, Oncology and Transplantation, University of Minnesota

Roger L. and Lynn C. Headrick Family Chair in Cancer Therapeutics, USA

Ali Mohamed

VP, CMC

Immatics, USA

Shashi Murthy, PhD

Professor of Chemical Engineering & Sherman Center Director

Northeastern University

Knut Niss

Chief Technology Officer

Mustang Bio, USA

Steve Oh

Director Stem Cell Bioprocessing & Institute Professor,

A*Star, Singapore

Bilal Omer

Assistant Professor

Baylor College of Medicine, USA

Anna Outhwaite

Head of ATTC Network Coordination

Cell and Gene Therapy Catapult, UK

Felicia Pagliuca

VP Cell Biology R&D

Semma Therapeutics, USA

Toby Peach

Theatre Maker, Writer & Director

Toby Peach, UK

Chad Presher

Associate Director, Clinical Drug Supply

Biogen, USA

Gabriele Proetzl

Director, Regenerative Medicine

Takeda, USA (pending final confirmation)

Qasim Rafik

Senior Lecturer in Bioprocessing of Regenerative, Cellular and Gene

UCL, UK

Lior Raviv

Vice President

Pluristem Therapeutics Inc.

Krzysztof Regulski

Head of CMC Project Management

GenSight Biologics, France

Jon A. Rowley, Ph.D.

Chief Executive & Technology Officer

RoosterBio Inc.

Brandy Sargent

Editor

Cell Culture Dish, USA

Franz Schnetzinger

Director Analytical Development

Gyroscrope, UK

Angela Scott

Founder & Chief Operating Officer at TC Biopharm, UK

TC Biopharm, UK

Donald Singer

GSK Senior Fellow, Microbiology, Biopharmaceutical GMP Operations

GSK, USA

David Smith

Chief Commercial Officer

Healios

Devyn Smith

Chief Strategy Officer and Head of Operations

Sigilon Therapeutics, USA

Austin Thiel

Senior Principal Scientist

Semma Therapeutics, USA

Nick Timmins, PhD

Vice President, Process Science

Bluerock Therapeutics

Wouter Van t’Hof

Cord Blood Bank Director

Cleveland Cord Blood Centre, USA

Craig Vermeyen

Senior Manager, Packaging Engineering

Kite, a Gilead Company, USA

Rosemary Versteegen, PhD

CEO

International Serum Industry Association

Loic Vincent

Head Oncology & Immunology Research Partnerships, Head of Cell Therapy Discovery

Takeda, USA

James Dean Vogel

Founder and Director

The BioProcess Institute

Xiuyan Wang

Assistant Director

Memorial Sloan Kettering Cancer Center, USA

Dan Wilkinson

Computational Biologist

BlueRock Therapeutics, USA

Erik Woods

Co-Founder and Chief Science Officer

Ossium Health, Inc., USA

Carolyn Yeago

Associate Director of Research

Marcus Center for Therapeutic Cell Characterization and Manufacturing, Georgia Institute of Technology, USA

Sanjin Zvonić

VP Process Science and Manufacturing

WindMIL Therapeutics, USA